664 related articles for article (PubMed ID: 19260819)
21. A comparison of the effectiveness of zanamivir and oseltamivir for the treatment of influenza A and B.
Kawai N; Ikematsu H; Iwaki N; Maeda T; Kanazawa H; Kawashima T; Tanaka O; Yamauchi S; Kawamura K; Nagai T; Horii S; Hirotsu N; Kashiwagi S
J Infect; 2008 Jan; 56(1):51-7. PubMed ID: 17936910
[TBL] [Abstract][Full Text] [Related]
22. Clinical effectiveness of oseltamivir for influenza A(H1N1) virus with H274Y neuraminidase mutation.
Kawai N; Ikematsu H; Iwaki N; Kondou K; Hirotsu N; Kawashima T; Maeda T; Tanaka O; Doniwa K; Kashiwagi S
J Infect; 2009 Sep; 59(3):207-12. PubMed ID: 19619898
[TBL] [Abstract][Full Text] [Related]
23. [Fatal pneumonitis due to oseltamivir-resistant new influenza A(H1N1) in the case of an intensive care patient].
Aardema H; Tulleken JE; van den Biggelaar RJ; Wolters BA; de Jager CM; Boucher CA; Riezebos-Brilman A
Ned Tijdschr Geneeskd; 2010; 154():A1634. PubMed ID: 20482913
[TBL] [Abstract][Full Text] [Related]
24. The use of antiviral agents for the management of severe influenza.
Smith JR; Ariano RE; Toovey S
Crit Care Med; 2010 Apr; 38(4 Suppl):e43-51. PubMed ID: 19935416
[TBL] [Abstract][Full Text] [Related]
25. In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against clinical isolates of the influenza virus circulating in the Japanese 2013-2014 season.
Ikematsu H; Kawai N; Iwaki N; Kashiwagi S
J Infect Chemother; 2015 Sep; 21(9):634-8. PubMed ID: 26096495
[TBL] [Abstract][Full Text] [Related]
26. Influenza virus susceptibility and resistance to oseltamivir.
Aoki FY; Boivin G; Roberts N
Antivir Ther; 2007; 12(4 Pt B):603-16. PubMed ID: 17944268
[TBL] [Abstract][Full Text] [Related]
27. Pomegranate (Punica granatum) purified polyphenol extract inhibits influenza virus and has a synergistic effect with oseltamivir.
Haidari M; Ali M; Ward Casscells S; Madjid M
Phytomedicine; 2009 Dec; 16(12):1127-36. PubMed ID: 19586764
[TBL] [Abstract][Full Text] [Related]
28. Modifying clinical practices to manage influenza in children effectively.
Glezen WP
Pediatr Infect Dis J; 2008 Aug; 27(8):738-43. PubMed ID: 18664986
[TBL] [Abstract][Full Text] [Related]
29. [Naturally occurring oseltamivir resistance in influenza A].
Madsen L; Nielsen A; Lundgren J
Ugeskr Laeger; 2010 Aug; 172(32):2165-7. PubMed ID: 20696118
[TBL] [Abstract][Full Text] [Related]
30. Comparison between virus shedding and fever duration after treating children with pandemic A H1N1/09 and children with A H3N2 with a neuraminidase inhibitor.
Sugaya N; Sakai-Tagawa Y; Bamba M; Yasuhara R; Yamazaki M; Kawakami C; Yamaguchi Y; Ide Y; Ichikawa M; Mitamura K; Kawaoka Y
Antivir Ther; 2015; 20(1):49-55. PubMed ID: 24832015
[TBL] [Abstract][Full Text] [Related]
31. Detection of human influenza A (H1N1) and B strains with reduced sensitivity to neuraminidase inhibitors.
Escuret V; Frobert E; Bouscambert-Duchamp M; Sabatier M; Grog I; Valette M; Lina B; Morfin F; Ferraris O
J Clin Virol; 2008 Jan; 41(1):25-8. PubMed ID: 18055253
[TBL] [Abstract][Full Text] [Related]
32. Dynamics of antiviral-resistant influenza viruses in the Netherlands, 2005-2008.
Jonges M; van der Lubben IM; Dijkstra F; Verhoef L; Koopmans M; Meijer A
Antiviral Res; 2009 Sep; 83(3):290-7. PubMed ID: 19591877
[TBL] [Abstract][Full Text] [Related]
33. Zanamivir treatment is equally effective for both influenza A and influenza B.
Kawai N; Ikematsu H; Iwaki N; Tanaka O; Yamanishi Y; Hirotsu N; Kashiwagi S
Clin Infect Dis; 2007 Jun; 44(12):1666. PubMed ID: 17516418
[No Abstract] [Full Text] [Related]
34. Different neuraminidase inhibitor susceptibilities of human H1N1, H1N2, and H3N2 influenza A viruses isolated in Germany from 2001 to 2005/2006.
Bauer K; Richter M; Wutzler P; Schmidtke M
Antiviral Res; 2009 Apr; 82(1):34-41. PubMed ID: 19428593
[TBL] [Abstract][Full Text] [Related]
35. Surveillance for neuraminidase-inhibitor-resistant influenza viruses in Japan, 1996-2007.
Tashiro M; McKimm-Breschkin JL; Saito T; Klimov A; Macken C; Zambon M; Hayden FG;
Antivir Ther; 2009; 14(6):751-61. PubMed ID: 19812437
[TBL] [Abstract][Full Text] [Related]
36. In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against influenza virus isolates in the 2011-2012 season in Japan.
Ikematsu H; Kawai N; Iwaki N; Kashiwagi S
J Infect Chemother; 2014 Feb; 20(2):77-80. PubMed ID: 24560563
[TBL] [Abstract][Full Text] [Related]
37. An unusual cause of fever in a neonate: influenza A (H1N1) virus pneumonia.
Sert A; Yazar A; Odabas D; Bilgin H
Pediatr Pulmonol; 2010 Jul; 45(7):734-6. PubMed ID: 20575093
[TBL] [Abstract][Full Text] [Related]
38. Long-acting neuraminidase inhibitor laninamivir octanoate versus oseltamivir for treatment of influenza: A double-blind, randomized, noninferiority clinical trial.
Watanabe A; Chang SC; Kim MJ; Chu DW; Ohashi Y;
Clin Infect Dis; 2010 Nov; 51(10):1167-75. PubMed ID: 20936975
[TBL] [Abstract][Full Text] [Related]
39. Insights from investigating the interaction of oseltamivir (Tamiflu) with neuraminidase of the 2009 H1N1 swine flu virus.
Wang SQ; Du QS; Huang RB; Zhang DW; Chou KC
Biochem Biophys Res Commun; 2009 Aug; 386(3):432-6. PubMed ID: 19523442
[TBL] [Abstract][Full Text] [Related]
40. Clinical effectiveness of neuraminidase inhibitors--oseltamivir, zanamivir, laninamivir, and peramivir--for treatment of influenza A(H3N2) and A(H1N1)pdm09 infection: an observational study in the 2010-2011 influenza season in Japan.
Shobugawa Y; Saito R; Sato I; Kawashima T; Dapat C; Dapat IC; Kondo H; Suzuki Y; Saito K; Suzuki H
J Infect Chemother; 2012 Dec; 18(6):858-64. PubMed ID: 22644080
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
